
Share on:
Arcam received an order for five Arcam Q10 systems from Beijing AK Medical, a present customer in China. The systems will be used for volume production of orthopaedic implants.
Beijing AK Medical, an Arcam customer since 2010, announced in August its formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM-manufactured implants. This was the first CFDA marketing approval for an additively manufactured orthopaedic implant.
Arcam Group provides Additive Manufacturing solutions for the production of metal components.
RELATED ARTICLES
Sandvik to Divest Additive Manufacturing Business Unit
Jun 16 2026 , Julie A. Vetalice
Cretex Medical Acquires Select Assets and Capabilities of Holland Molds
Jun 16 2026 , Julie A. Vetalice
Medical Component Specialists Appoints President & CEO
Jun 15 2026 , Julie A. Vetalice



